» Articles » PMID: 32980980

Cricopharyngeal Bar on Videofluoroscopy: High Specificity for Inclusion Body Myositis

Overview
Journal J Neurol
Specialty Neurology
Date 2020 Sep 27
PMID 32980980
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the prevalence and characteristics of the cricopharyngeal bar (CPB), defined as marked protrusion with lacking relaxation and stricture of the upper esophageal sphincter on videofluoroscopy, in patients with inclusion body myositis (IBM).

Methods: We conducted a case-control study of comprehensive series of adult healthy individuals and consecutive patients with neuropsychiatric disorders aged over 45 (52 versus 2486). A standard videofluoroscopy was performed.

Results: Overall, 47 individuals with CPB were identified. Of the individuals with CPB, 36% were IBM followed by neurodegenerative disorders, muscular disorders, neuromuscular disorders, and others (32%, 21%, 2.1%, and 8.5%, respectively), indicating the heterogeneity of the etiologies. Against muscular disorders, the sensitivity and specificity of the CPB for IBM were 33% (= 17/52; 95% confidence interval [CI], 20-45%) and 96% (= 264/274; 95% CI, 94-99%), respectively. IBM with CPB showed a higher frequency of obstruction-related dysphagia (88% versus 22%, p < 0.001) and severe CPB (76% versus 23%, p < 0.001) than the control with one. The ratio of the upper esophageal distance at the maximum distension at the level of C6 to that of C4 was lower in IBM with CPB than in the controls with one (0.50 versus 0.77, p < 0.001), which suggests the insufficient opening of the upper esophageal sphincter.

Conclusion: A CPB could be indicative of IBM. The upper esophagus in IBM with CPB became narrow, like a bottleneck. We provide new perspectives of dysphagia diagnosis by videofluoroscopy, especially for IBM-associated dysphagia, to expand the knowledge on the CPB.

Citing Articles

Differentiating Inclusion Body Myositis From Amyotrophic Lateral Sclerosis Based on the Features of Dysphagia: Insights From a Patient With Rapidly Progressive Dysphagia.

Je Y, Park Y, Shin Y J Clin Neurol. 2025; 21(1):83-85.

PMID: 39778572 PMC: 11711274. DOI: 10.3988/jcn.2024.0134.


Retrograde Cricopharyngeal Dysfunction: A Review.

Miller M, Lina I, Akst L J Clin Med. 2024; 13(2).

PMID: 38256547 PMC: 10817096. DOI: 10.3390/jcm13020413.


Efficacy of endoscopic cricopharyngeal myotomy using a curved rigid laryngoscope in patients with sporadic inclusion body myositis: four retrospective case reviews.

Shigeyama M, Nishio N, Yokoi S, Mukoyama N, Wada A, Maruo T Nagoya J Med Sci. 2023; 85(4):866-874.

PMID: 38155617 PMC: 10751494. DOI: 10.18999/nagjms.85.4.866.


Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction.

Wei P Toxins (Basel). 2022; 14(5).

PMID: 35622568 PMC: 9147508. DOI: 10.3390/toxins14050321.

References
1.
Cox F, Verschuuren J, Verbist B, Niks E, Wintzen A, Badrising U . Detecting dysphagia in inclusion body myositis. J Neurol. 2009; 256(12):2009-13. PMC: 2780610. DOI: 10.1007/s00415-009-5229-9. View

2.
Cox F, Titulaer M, Sont J, Wintzen A, Verschuuren J, Badrising U . A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain. 2011; 134(Pt 11):3167-75. DOI: 10.1093/brain/awr217. View

3.
Dietz F, Logeman J, Sahgal V, SCHMID F . Cricopharyngeal muscle dysfunction in the differential diagnosis of dysphagia in polymyositis. Arthritis Rheum. 1980; 23(4):491-5. DOI: 10.1002/art.1780230412. View

4.
Kagen L, Hochman R, Strong E . Cricopharyngeal obstruction in inflammatory myopathy (polymyositis/dermatomyositis). Report of three cases and review of the literature. Arthritis Rheum. 1985; 28(6):630-6. DOI: 10.1002/art.1780280606. View

5.
Danon M, Friedman M . Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy. Can J Neurol Sci. 1989; 16(4):436-8. DOI: 10.1017/s031716710002953x. View